215 related articles for article (PubMed ID: 21106222)
21. Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma.
Karonen T; Jeskanen L; Keski-Oja J
Br J Dermatol; 1997 Jul; 137(1):51-8. PubMed ID: 9274625
[TBL] [Abstract][Full Text] [Related]
22. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
[TBL] [Abstract][Full Text] [Related]
23. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
24. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
Hoang CD; Zhang X; Scott PD; Guillaume TJ; Maddaus MA; Yee D; Kratzke RA
Cancer Res; 2004 Oct; 64(20):7479-85. PubMed ID: 15492273
[TBL] [Abstract][Full Text] [Related]
25. Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung.
Leppäranta O; Sens C; Salmenkivi K; Kinnula VL; Keski-Oja J; Myllärniemi M; Koli K
Cell Tissue Res; 2012 Jun; 348(3):491-503. PubMed ID: 22434388
[TBL] [Abstract][Full Text] [Related]
26. Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.
Koli K; Wempe F; Sterner-Kock A; Kantola A; Komor M; Hofmann WK; von Melchner H; Keski-Oja J
J Cell Biol; 2004 Oct; 167(1):123-33. PubMed ID: 15466481
[TBL] [Abstract][Full Text] [Related]
27. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
Kantola AK; Keski-Oja J; Koli K
Exp Cell Res; 2008 Aug; 314(13):2488-500. PubMed ID: 18585707
[TBL] [Abstract][Full Text] [Related]
28. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
Roth-Eichhorn S; Kühl K; Gressner AM
Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
[TBL] [Abstract][Full Text] [Related]
30. Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma.
Cordier Kellerman L; Valeyrie L; Fernandez N; Opolon P; Sabourin JC; Maubec E; Le Roy P; Kane A; Legrand A; Abina MA; Descamps V; Haddada H
Cancer Gene Ther; 2003 Jun; 10(6):481-90. PubMed ID: 12768194
[TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Koli K; Keski-Oja J
Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
[TBL] [Abstract][Full Text] [Related]
32. Expression of transforming growth factor beta isoforms and their receptors during hair growth phases in mice.
Wollina U; Lange D; Funa K; Paus R
Histol Histopathol; 1996 Apr; 11(2):431-6. PubMed ID: 8861766
[TBL] [Abstract][Full Text] [Related]
33. Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.
Koli K; Saharinen J; Kärkkäinen M; Keski-Oja J
J Cell Sci; 2001 Aug; 114(Pt 15):2869-78. PubMed ID: 11683420
[TBL] [Abstract][Full Text] [Related]
34. Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
Saharinen J; Hyytiäinen M; Taipale J; Keski-Oja J
Cytokine Growth Factor Rev; 1999 Jun; 10(2):99-117. PubMed ID: 10743502
[TBL] [Abstract][Full Text] [Related]
35. Disruption of the latent transforming growth factor-beta binding protein-1 gene causes alteration in facial structure and influences TGF-beta bioavailability.
Drews F; Knöbel S; Moser M; Muhlack KG; Mohren S; Stoll C; Bosio A; Gressner AM; Weiskirchen R
Biochim Biophys Acta; 2008 Jan; 1783(1):34-48. PubMed ID: 17950478
[TBL] [Abstract][Full Text] [Related]
36. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.
Saharinen J; Keski-Oja J
Mol Biol Cell; 2000 Aug; 11(8):2691-704. PubMed ID: 10930463
[TBL] [Abstract][Full Text] [Related]
37. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of tenascin-C in malignant pleural mesothelioma.
Kaarteenaho-Wiik R; Soini Y; Pöllänen R; Pääkkö P; Kinnula VL
Histopathology; 2003 Mar; 42(3):280-91. PubMed ID: 12605648
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.
Saharinen J; Taipale J; Monni O; Keski-Oja J
J Biol Chem; 1998 Jul; 273(29):18459-69. PubMed ID: 9660815
[TBL] [Abstract][Full Text] [Related]
40. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
